Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis

Digestive Diseases and Sciences

Volumn 43, Issue 7, 1998, Pages 1572-1579

  Kajiwara, Kenta ^a   Okuno, Masataka ^a   Kobayashi, Tetsuo ^a   Honma, Nobuko ^a   Maki, Toshio ^a   Kato, Masahiko ^a   Ohnishi, Hiroo ^a   Muto, Yasutoshi ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Albumin; Ammonia; Branched chain amino acids; Carbon tetrachloride; Liver cirrhosis; Survival rate

Indexed keywords

ALBUMIN; AMMONIA; BRANCHED CHAIN AMINO ACID; CARBON TETRACHLORIDE; CASEIN; ISOLEUCINE; LEUCINE; VALINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERAMMONEMIA; HYPOALBUMINEMIA; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; SURVIVAL;

ADMINISTRATION, ORAL; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; CARBON TETRACHLORIDE POISONING; CASEINS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS;

EID: 0031854274     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018831302578     Document Type: Article

References (43)

1. Morgan AG, Kelleher J, Walker BE, Losowsky MS: Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 17:113-118, 1976
2. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N, Copenhagen Study Group For Liver Disease: Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 4:430-435, 1984
3. Merkel C, Bolognesi M, Finucci GF, Angeli P, Caregaro L, Rondana M, Gatta A: Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. J Hepatol 9:16-22, 1989
4. Campillo B, Nhi Bories P, Pornin B, Devanlay M: Influence of liver failure, ascites and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 13:613-621, 1997
5. Müller MJ, Böker KHW, Selberg O: Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin Invest 72:568-579, 1994
6. Müller MJ, Lautz HU, Plogman B, Bürger M, Körber J, Schmidt FW: Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state. Hepatology 15:782-794, 1992
7. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ: Identification of high- or low-risk patients before liver transplantation: A prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25:652-657, 1997
8. Müller MJ, Loyal M, Schwarze M, Lobers J, Selberg O, Ringe B, Pichlmayr R: Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation. Clin Nutr 13:145-152, 1994
9. Freund H, Yoshimura N, Lunetta L, Fischer JE: The role of the branched-chain amino acids in decreasing muscle catabolism in vitro. Surgery 83:611-618, 1978
10. Müller MJ: On the impact of the metabolic state in cirrhotic patients. Nutrition 13:687-688, 1997
11. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F: Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusion. Am J Surg 127:40-47, 1974
12. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE: Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72:483-487, 1977
13. Goldberg AL, Chang TW: Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc 37:2301-2307, 1978
14. Hayashi M, Ohnishi H, Kawade Y, Muto Y, Takahashi Y: Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special reference to ammonia detoxication. J Gastroenterol (Gastroenterol Jpn) 16:64-70, 1981
15. Fischer JE, Baldessarini RJ: False neurotransmitters and hepatic failure. Lancet 2:75-80, 1971
16. Munro HN, Fernstrom JD, Wurtman RJ: Insulin, plasma amino acid imbalance, and hepatic coma. Lancet 1:722-724, 1975
17. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB: The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77-91, 1976
18. Kawade Y, Muto Y: Pathophysiology and intervention of hepatic encephalopathy with special reference to amino acid imbalance. J Gastroenterol (Gastroenterol Jpn) 16:405, 1981
19. Muto Y: Medical intervention by special amino acid preparation: clinical improvements of hepatic encephalopathy and protein malnutritional status in patients with liver cirrhosis. J Gastroenterol (Gastroenterol Jpn) 17:615-616, 1982
20. Chalasuni N, Gitlin N: Severe recurrent hepatic encephalopathy that respond to oral branched chain amino acids. Am J Gastroenterol 91:1266-1268, 1996
21. Marchesini G, Zoli M, Falla V, Bianchi FB, Pisi E: Urinary excretion of 3′-methylhistidine in advanced liver cirrhosis. Ital J Gastroenterol 11:70-71, 1979
22. Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E: Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 2:420-425, 1982
23. Muto Y, Yoshida T, Yamatoh M: Clinical assessment of nutritional status in patients with liver cirrhosis with special reference to plasma amino acid imbalance. J Clin Biochem Nutr 1:89-95, 1986
24. Charlton MR: Branched chains revisited. Gastroenterology 111:252-255, 1996
25. Jürgens P: New aspects of etiology, biochemistry, and therapy of portal systemic encephalopathy: A critical survey. Nutrition 13:560-570, 1997
26. Riordan SM, Williams R: Treatment of hepatic encephalopathy. N Engl J Med 337:473-479, 1997
27. Fulks RM, Li JB, Goldberg AL: Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem 250:290-298, 1975
28. Swart GR, Frenkel M, van den Berg JWO: Minimum protein requirements in advanced liver disease. A metabolic ward study of the effects of oral branched-chain amino acids. In Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids. M Walser, JR Williamson (eds). New York, Elsevier North Holland, 1981, pp 427-432
29. Swart GR, van den Berg JWO, van Vuure JK, Rietveld T, Wattimena DL, Freukel M: Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 8:329-336, 1989
30. Muto Y, Yoshida T: Effect of oral supplementation with branched-chain amino acid granules on improvement of protein nutrition in decompensated liver cirrhosis: A cross-over controlled study. In Parenteral and Enteral Hyperalimentation. S Ogoshi, A Okada (eds). Amsterdam, Elsevier Science Publishers, 1984, pp 281-292
31. Yoshida T, Muto Y, Moriwaki H, Yamato M: Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. J Gastroenterol (Gastroenterol Jpn) 24:692-698, 1989
32. Okuno M, Moriwaki H, Kato M, Muto Y, Kojima S: Changes in the ratio of branched-chain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes. Biochem Biophys Res Commun 214:1045-1050, 1995
33. Usui T, Moriwaki H, Hatakeyama H, Kasai T, Kato M, Seishima M, Okuno M, Ohnishi H, Yoshida T, Muto Y: Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J Nutr 126:1412-1420, 1996
34. Proctor E, Chatamra K: Standard micronodular cirrhosis in the rat. Eur Surg Res 16:182-186, 1984
35. Ohashi H, Sukegawa E, Takami T, Yoshida T, Muto Y: Effects of supplementation with branched-chain amino acids on protein-nutritional status in rats treated by carbon tetrachloride. Jpn J Gastroenterol 86:1645-1653, 1989
36. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numeric scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
37. Strobel JL, Cady SG, Borg TK, Terracio L, Baynes JW, Thrope SR: Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. J Biol Chem 261:7989-7994, 1986
38. Kato M, Yoshida T, Moriwaki H, Muto Y: Effect of branched-chain amino acid (BCAA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients. Acta Hepatol Jpn 32:692-699, 1991
39. Miwa Y, Kato M, Moriwaki H, Okuno M, Sugihara J, Ohnishi H, Yoshida T, Muto Y, Nakayama M, Morioka Y, Asagi K: Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure. Hepatology 22:291-296, 1995
40. Yamato Y, Muto Y, Yoshida T, Kato M, Moriwaki H: Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. Int Hepatol Commun 3:91-96, 1995
41. Holm E, Leweling H, Staedt U, Striebel JP, Jacobs S: The metabolic fate of branched-chain amino acids. In Hepatic Encephalopathy in Chronic Liver Failure. L Capocaccia, JE Fischer, F Rossi-Fannelli (eds). New York, Plenum Press, 1984, p 161
42. Crawford DHG, Shepherd RW, Halliday JW, Cooksley GWGE, Golding SD, Cheng WSC, Powell LW: Body composition in nonalcoholic cirrhosis: The effect of disease etiology and severity on nutritional compartments. Gastroenterology 106:1611-1617, 1994
43. American Institute of Nutrition: Report of the American Institute of Nutrition ad hoc committe on standards for nutritional studies. J Nutr 107:1340-1348, 1977